Cargando…

Dysregulated Humoral and Cellular Response to Sars-Cov-2 Vaccination in Patients with MGUS and SMM

Detalles Bibliográficos
Autores principales:	Konishi, Yoshinobu, Sklavenitis-Pistofidis, Romanos, Aranha, Michelle P., Wu, Ting, Yue, Hong, Lightbody, Elizabeth D., Rahmat, Mahshid, Timonian, Michael, Varmeh, Shohreh, Heilpern-Mallory, Daniel, Agius, Michael P., Su, Nang Kham, Perry, Jacqueline, Horowitz, Erica, Davis, Maya I., Justis, Anna V., Nowak, Radoslaw P., Hamilton, Mark, Auclair, Daniel, Marinac, Catherine R., Fischer, Eric S., Getz, Gad, Ghobrial, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665239/ http://dx.doi.org/10.1182/blood-2022-167212

Ejemplares similares

Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
por: Konishi, Yoshinobu, et al.
Publicado: (2022)

Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and Challenges
por: Sklavenitis-Pistofidis, Romanos, et al.
Publicado: (2022)

Using genomics to better define high-risk MGUS/SMM patients
por: Dutta, Ankit K., et al.
Publicado: (2018)

Bone marrow niche in multiple myeloma and its precursor states
por: Sklavenitis-Pistofidis, Romanos, et al.
Publicado: (2019)

Mass cytometry staining for human bone marrow clinical samples
por: Hallisey, Margaret, et al.
Publicado: (2022)

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability
por: Dutta, Ankit K., et al.
Publicado: (2018)

Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors
por: Sklavenitis-Pistofidis, Romanos, et al.
Publicado: (2023)

MGUS bone
por: Imataki, Osamu, et al.
Publicado: (2019)

Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
por: Lomas, Oliver C., et al.
Publicado: (2020)

Inheritance in MGUS and MM
por: Pfreundschuh, Michael
Publicado: (2015)

Probing Biology with Small Molecule Microarrays (SMM)
por: Winssinger, Nicolas, et al.
Publicado: (2007)

Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis
por: Boiarsky, Rebecca, et al.
Publicado: (2022)

Transfer of knowledge in international cooperation: the Farmanguinhos – SMM case
por: da Silva, Samuel Araujo Gomes, et al.
Publicado: (2017)

Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes
por: Bustoros, Mark, et al.
Publicado: (2022)

Psychometric properties of the Stress Mindset Measure (SMM) in the Polish population
por: Mierzejewska-Floreani, Dorota, et al.
Publicado: (2022)

Russian adaptation of Stress Mindset Measure-General (SMM-G)
por: Lebedeva, N., et al.
Publicado: (2022)

Two Cases of Heavy Chain MGUS
por: Van Keer, Jan, et al.
Publicado: (2016)

Severe CIDP-MGUS responsive to Rituximab
por: Posa, Andreas, et al.
Publicado: (2020)

Active multiple myeloma suppresses and typically eliminates coexisting MGUS
por: Campbell, John P, et al.
Publicado: (2017)

Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma
por: Knight, Andrea, et al.
Publicado: (2021)

P851: TARGETING GENE DEPENDENCIES IN MYC OVEREXPRESSING MULTIPLE MYELOMA
por: Hasan Bou Issa, L., et al.
Publicado: (2022)

Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist
por: Presley, Chaela, et al.
Publicado: (2015)

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
por: Mateos, María-Victoria, et al.
Publicado: (2020)

Reproducibility of isokinetic knee testing using the novel isokinetic SMM iMoment dynamometer
por: Kambič, Tim, et al.
Publicado: (2020)

MGUS Predicts Worse Prognosis in Patients with Coronary Artery Disease
por: Xu, Zhao, et al.
Publicado: (2020)

Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS)
por: Zushi, Yuriko, et al.
Publicado: (2019)

Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Pang, Li, et al.
Publicado: (2021)

Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia
por: Bouyssou, Juliette M., et al.
Publicado: (2018)

Assessing the Influence of Child Sexual Behavior on Depression among Black SMM in the Southeastern United States
por: Boyd, Donte Travon, et al.
Publicado: (2022)

Determination of vanillin in different food samples by using SMM/Au@ZIF-67 electrochemical sensor
por: Dehdashtian, Sara, et al.
Publicado: (2023)

A Case of Crystalline Keratopathy in Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Koo, Hyun, et al.
Publicado: (2011)

The effect of azacitidine therapy on the M protein of MDS patients with concomitant MGUS
por: Oka, Satoko, et al.
Publicado: (2018)

Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients
por: Bosseboeuf, Adrien, et al.
Publicado: (2020)

IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration
por: Ruhe, Johannes, et al.
Publicado: (2020)

Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients
por: Visram, A., et al.
Publicado: (2021)

An Unexpected Finding in a Patient with AKI, Nephrotic Range Proteinuria, and MGUS
por: Scurt, Florian G., et al.
Publicado: (2023)

Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma
por: Ludwig, C, et al.
Publicado: (2015)

Strong Exchange Couplings Drastically Slow Down Magnetization Relaxation in an Air‐Stable Cobalt(II)‐Radical Single‐Molecule Magnet (SMM)
por: Albold, Uta, et al.
Publicado: (2019)

4473 Immune control of plasma cell disorders – in-depth analysis of Sox2 immunity in MGUS
por: Susanibar Adaniya, Sandra Patricia, et al.
Publicado: (2020)

A gene signature can predict risk of MGUS progressing to multiple myeloma
por: Sun, Fumou, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jsjbpcfq5do8v63ekbhhfmgqq1